|
Robert C. Bishop, Ph.D.,
President & CEO,
AutoImmune Inc.
Albert S.B. Edge, Ph.D.,
Senior Director,
Molecular and Cellular Biology,
Diacrin Inc.
Henry A. Erlich, Ph.D.,
Director,
Department of Human Genetics,
Roche Molecular Systems
Robert P. Lanza, M.D.,
Director of Transplantation Biology,
BioHybrid Technologies Inc.
Mike Metzker, Ph.D.,
Senior Research Biologist,
Human Genetics,
Merck & Co. |
Christopher B. Newgard, Ph.D.,
Professor,
Departments of Biochemistry & Internal Medicine,
Gifford Laboratories for Diabetes Research,
University of Texas Southwestern Medical Center; Founding Scientist,
BetaGene, Inc.
Ammon B. Peck, Ph.D.,
Professor,
Department of Pathology & Lab Medicine,
University of Florida
Larry Peterson, Ph.D.,
Director of Pharmacology,
Merck Research Laboratories
Eva-Pia Reich, Ph.D.,
Senior Scientist,
Department of Immunology,
Anergen, Inc. |
David W. Scharp, M.D.,
Chief Scientific Officer,
Neocrin Company
Timothy A. Stewart, Ph.D.,
Staff Scientist,
Endocrinology and Metabolism,
Genentech Inc.
Yi Wang, M.D.,
Senior Staff Scientist,
Alexion Pharmaceuticals Inc.
Dale Wegmann, Ph.D.,
Assistant Professor,
Barbara Davis Center for Childhood Diabetes,
University of Colorado Health Sciences Center |
